Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Torti

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Cancer Research|September 1, 1993
Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humansM J Bargetzi, M Lantz, C G Smith, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1989
Efficient scheduling of cystoscopies in monitoring for recurrent bladder cancerD L Kent, R Shachter, H C Sox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Weekly doxorubicin in endocrine-refractory carcinoma of the prostateF M Torti, D Aston, B L Lum, et al.
The Journal of Urology|December 1, 1985
The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group studyF J Meyers, J M Palmer, F S Freiha, et al.
The Journal of Clinical Investigation|July 1, 1993
Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1M Mohtai, R L Smith, D J Schurman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitroH Ito, S C Miller, M E Billingham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group studyW G Harker, F J Meyers, F S Freiha, et al.
The Journal of Biological Chemistry|September 5, 1988
The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible geneS V Torti, E L Kwak, S C Miller, et al.
Carcinogenesis|September 29, 2001
p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelatorR D Abeysinghe, B T Greene, R Haynes, et al.
Annals of Internal Medicine|December 1, 1983
Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsyF M Torti, M R Bristow, A E Howes, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer Research|September 1, 1993
Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humansM J Bargetzi, M Lantz, C G Smith, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1989
Efficient scheduling of cystoscopies in monitoring for recurrent bladder cancerD L Kent, R Shachter, H C Sox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1983
Weekly doxorubicin in endocrine-refractory carcinoma of the prostateF M Torti, D Aston, B L Lum, et al.
The Journal of Urology|December 1, 1985
The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group studyF J Meyers, J M Palmer, F S Freiha, et al.
The Journal of Clinical Investigation|July 1, 1993
Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1M Mohtai, R L Smith, D J Schurman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitroH Ito, S C Miller, M E Billingham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group studyW G Harker, F J Meyers, F S Freiha, et al.
The Journal of Biological Chemistry|September 5, 1988
The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible geneS V Torti, E L Kwak, S C Miller, et al.
Carcinogenesis|September 29, 2001
p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelatorR D Abeysinghe, B T Greene, R Haynes, et al.
Annals of Internal Medicine|December 1, 1983
Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsyF M Torti, M R Bristow, A E Howes, et al.
Pageof 9